Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Men with male pattern baldness had higher body fat and obesity-related measurements but similar heart fat and artery thickness compared to healthy men.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

PCOS patients have more central body fat, which can be effectively measured using DEXA.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

The normal human prostate does not significantly affect blood DHT levels.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Baldness may lower the risk of testicular cancer.

Acne treatment with isotretinoin increases the presence of p53, a protein, in skin and oil glands, which may help reduce acne severity.

Males with male pattern baldness have higher blood galectin-3 levels.

New information suggests that metformin might help more women with PCOS and infertility, not just those with glucose issues.

Cinnamon can help manage symptoms of polycystic ovary syndrome, improve menstrual cycles and fertility, and positively affect cholesterol and blood sugar levels, but more research is needed to confirm these effects and find the best dosage.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Vitamin D levels in hair don't match those in blood, so hair isn't a reliable indicator of Vitamin D status.

Obesity is linked to various skin conditions and issues, and losing weight can improve these conditions.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.